反应详情

The title compound was synthesized in a similar manner as described for Example 1.1 using 8-bromo-1-(1,3-dimethyl-1H-pyrazol-4-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one (Intermediate A, 40 mg, 0.105 mmol) and 3-fluoro-2-methoxypyridine-5-boronic acid (Apollo Scientific, Cheshire, United Kingdom, 21 mg, 0.123 mmol) to give the title compound as a pink solid. (HPLC: tR 2.70 min (Method A); M+H=419 MS-ES; 1H-NMR (d6-DMSO, 400 MHz) 8.97 (s, 1H), 8.18-8.05 (m, 3H), 7.96-7.89 (m, 1H), 7.81-7.74 (m, 1H), 7.49 (s, 1H), 3.99 (s, 3H), 3.92 (s, 3H), 3.59 (s, 3H), 1.98 (s, 3H))

1. customThe title compound was synthesized in a similar manner